SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-121793
Filing Date
2014-03-28
Accepted
2014-03-28 17:17:40
Documents
10
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d662955d10k.htm 10-K 1883072
2 EX-10.26 d662955dex1026.htm EX-10.26 3080
3 EX-10.31 d662955dex1031.htm EX-10.31 9595
4 EX-21.1 d662955dex211.htm EX-21.1 901
5 EX-23.1 d662955dex231.htm EX-23.1 1447
6 EX-31.1 d662955dex311.htm EX-31.1 5369
7 EX-31.2 d662955dex312.htm EX-31.2 5367
8 EX-32.1 d662955dex321.htm EX-32.1 3915
9 EX-32.2 d662955dex322.htm EX-32.2 3908
10 GRAPHIC g662955g79d34.jpg GRAPHIC 38682
  Complete submission text file 0001193125-14-121793.txt   1971068
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36297 | Film No.: 14726840
SIC: 2834 Pharmaceutical Preparations